Dolby Laboratories (DLB) Shareholder's Equity (2016 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Relx |
81.40 Bn |
81.16 Bn |
- |
3.15 Bn |
| 2 |
Rentokil Initial |
79.56 Bn |
78.10 Bn |
- |
5.50 Bn |
| 3 |
Cintas |
69.26 Bn |
69.08 Bn |
1.45 Bn |
4.79 Bn |
| 4 |
Copart |
33.09 Bn |
28.01 Bn |
971.24 Mn |
9.79 Bn |
| 5 |
UL Solutions |
20.56 Bn |
20.32 Bn |
381.00 Mn |
1.34 Bn |
| 6 |
Global Payments |
19.88 Bn |
14.69 Bn |
1.70 Bn |
23.79 Bn |
| 7 |
Rb Global |
19.08 Bn |
18.89 Bn |
869.50 Mn |
5.62 Bn |
| 8 |
Aramark |
13.57 Bn |
13.16 Bn |
426.35 Mn |
3.28 Bn |
| 9 |
Amentum Holdings |
5.65 Bn |
5.74 Bn |
345.00 Mn |
4.70 Bn |
| 10 |
Dolby Laboratories |
5.15 Bn |
4.56 Bn |
350.90 Mn |
2.62 Bn |
| Date | Value |
|---|
| Mar 27, 2026 |
2.62 Bn |
| Dec 26, 2025 |
2.60 Bn |
| Sep 26, 2025 |
2.62 Bn |
| Jun 27, 2025 |
2.60 Bn |
| Mar 28, 2025 |
2.58 Bn |
| Dec 27, 2024 |
2.52 Bn |
| Sep 27, 2024 |
2.49 Bn |
| Jun 28, 2024 |
2.45 Bn |
| Mar 29, 2024 |
2.44 Bn |
| Dec 29, 2023 |
2.36 Bn |
| Sep 29, 2023 |
2.37 Bn |
| Jun 30, 2023 |
2.38 Bn |
| Mar 31, 2023 |
2.36 Bn |
| Dec 30, 2022 |
2.29 Bn |
| Sep 30, 2022 |
2.25 Bn |
| Jul 1, 2022 |
2.46 Bn |
| Apr 1, 2022 |
2.61 Bn |
| Dec 31, 2021 |
2.64 Bn |
| Sep 24, 2021 |
2.60 Bn |
| Jun 25, 2021 |
2.63 Bn |
| Mar 26, 2021 |
2.59 Bn |
| Dec 25, 2020 |
2.57 Bn |
| Sep 25, 2020 |
2.44 Bn |
| Jun 26, 2020 |
2.44 Bn |
| Mar 27, 2020 |
2.37 Bn |
| Dec 27, 2019 |
2.34 Bn |
| Sep 27, 2019 |
2.31 Bn |
| Jun 28, 2019 |
2.32 Bn |
| Mar 29, 2019 |
2.35 Bn |
| Dec 28, 2018 |
2.35 Bn |
| Sep 28, 2018 |
2.37 Bn |
| Jun 29, 2018 |
2.39 Bn |
| Mar 30, 2018 |
2.43 Bn |
| Dec 29, 2017 |
2.34 Bn |
| Sep 29, 2017 |
2.40 Bn |
| Jun 30, 2017 |
2.12 Bn |
| Mar 31, 2017 |
2.04 Bn |
| Dec 30, 2016 |
2.00 Bn |
| Sep 30, 2016 |
2.23 Bn |
| Jul 1, 2016 |
1.94 Bn |
